Rtw Investments, LP Acadia Pharmaceuticals Inc Call Options Transaction History
Rtw Investments, LP
- $7.48 Billion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ACAD
# of Institutions
374Shares Held
162MCall Options Held
1.47MPut Options Held
1.1M-
Baker Bros. Advisors LP New York, NY42.9MShares$1.03 Billion7.46% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.2MShares$365 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$290 Million0.0% of portfolio
-
State Street Corp Boston, MA7.26MShares$174 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.13MShares$75.2 Million0.0% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.89B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...